Literature DB >> 11299004

The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum.

J C Vis1, M M Verbeek, R M de Waal, H J ten Donkelaar, B Kremer.   

Abstract

The mitochondrial toxin 3-nitropropionic acid (3-NP) causes selective striatal lesions in rats and serves as an experimental model for the neurodegenerative disorder Huntington's disease (HD). Apoptotic cell death has been implicated for the neuronal degeneration that occurs in HD brains. The present study was designed to investigate whether the 3-NP-induced cell death in rats involves apoptosis and an altered expression of Bcl-2 family proteins. Systemic administration of 3-NP via subcutaneous Alzet pumps resulted in lesions of variable severity with neuronal loss and gliosis in the striatum. Using the terminal transferase-mediated biotinylated-UTP nick end-labelling (TUNEL) of DNA, TUNEL-positive cells exhibiting typical apoptotic morphology were detected only in the striatum of rats with a severe lesion. Furthermore, the neuronal expression of the pro-apoptotic protein Bax was strongly increased in the core of the severe lesion. Expression of the anti-apoptotic marker Bcl-2 was unchanged in this location, but was enhanced in the margins of the lesions. A moderately increased expression of both Bax and Bcl-2 was observed in dark neurones in the mild lesion and in the subtle lesion. The presence of nuclear DNA fragmentation, strong granular Bax expression and an increased Bax/Bcl-2 ratio in the centre of severe lesions suggests the occurrence of apoptotic cell death following 3-NP administration. In contrast, the dark compromised neurones observed in 3-NP-treated animals revealed an equally enhanced expression of both Bax and Bcl-2, but lacked TUNEL-labelling, and are therefore not apoptotic.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299004     DOI: 10.1046/j.0305-1846.2001.00305.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  6 in total

1.  Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.

Authors:  Surekha Ramachandran; Sumathi Thangarajan
Journal:  Metab Brain Dis       Date:  2018-05-31       Impact factor: 3.584

Review 2.  Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases.

Authors:  A Cristina Rego; Catarina R Oliveira
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

3.  Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.

Authors:  Martin Köllensperger; Florian Krismer; Anton Pallua; Nadia Stefanova; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2011-01-06       Impact factor: 10.338

4.  Pyroptotic cell death in the R6/2 mouse model of Huntington's disease: new insight on the inflammasome.

Authors:  Emanuela Paldino; Vincenza D'Angelo; Giuseppe Sancesario; Francesca R Fusco
Journal:  Cell Death Discov       Date:  2020-07-31

5.  Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database.

Authors:  Ravi Kiran Reddy Kalathur; Miguel A Hernández-Prieto; Matthias E Futschik
Journal:  BMC Neurol       Date:  2012-06-28       Impact factor: 2.474

6.  PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Antonella Cardinale; Emanuela Paldino; Carmela Giampà; Giorgio Bernardi; Francesca R Fusco
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.